Literature DB >> 33475518

Risk Stratification for Early Detection of Diabetes and Hypertension in Resource-Limited Settings: Machine Learning Analysis.

Justin J Boutilier1, Timothy C Y Chan2, Manish Ranjan3, Sarang Deo4.   

Abstract

BACKGROUND: The impending scale up of noncommunicable disease screening programs in low- and middle-income countries coupled with limited health resources require that such programs be as accurate as possible at identifying patients at high risk.
OBJECTIVE: The aim of this study was to develop machine learning-based risk stratification algorithms for diabetes and hypertension that are tailored for the at-risk population served by community-based screening programs in low-resource settings.
METHODS: We trained and tested our models by using data from 2278 patients collected by community health workers through door-to-door and camp-based screenings in the urban slums of Hyderabad, India between July 14, 2015 and April 21, 2018. We determined the best models for predicting short-term (2-month) risk of diabetes and hypertension (a model for diabetes and a model for hypertension) and compared these models to previously developed risk scores from the United States and the United Kingdom by using prediction accuracy as characterized by the area under the receiver operating characteristic curve (AUC) and the number of false negatives.
RESULTS: We found that models based on random forest had the highest prediction accuracy for both diseases and were able to outperform the US and UK risk scores in terms of AUC by 35.5% for diabetes (improvement of 0.239 from 0.671 to 0.910) and 13.5% for hypertension (improvement of 0.094 from 0.698 to 0.792). For a fixed screening specificity of 0.9, the random forest model was able to reduce the expected number of false negatives by 620 patients per 1000 screenings for diabetes and 220 patients per 1000 screenings for hypertension. This improvement reduces the cost of incorrect risk stratification by US $1.99 (or 35%) per screening for diabetes and US $1.60 (or 21%) per screening for hypertension.
CONCLUSIONS: In the next decade, health systems in many countries are planning to spend significant resources on noncommunicable disease screening programs and our study demonstrates that machine learning models can be leveraged by these programs to effectively utilize limited resources by improving risk stratification. ©Justin J Boutilier, Timothy C Y Chan, Manish Ranjan, Sarang Deo. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 21.01.2021.

Entities:  

Keywords:  diabetes; global health; hypertension; machine learning; screening

Mesh:

Year:  2021        PMID: 33475518      PMCID: PMC7862003          DOI: 10.2196/20123

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  19 in total

Review 1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

Review 2.  Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin.

Authors:  F P Cappuccio
Journal:  J Hum Hypertens       Date:  1997-09       Impact factor: 3.012

3.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

Authors:  Peter W F Wilson; James B Meigs; Lisa Sullivan; Caroline S Fox; David M Nathan; Ralph B D'Agostino
Journal:  Arch Intern Med       Date:  2007-05-28

4.  Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data.

Authors:  Stefan Ravizza; Tony Huschto; Anja Adamov; Lars Böhm; Alexander Büsser; Frederik F Flöther; Rolf Hinzmann; Helena König; Scott M McAhren; Daniel H Robertson; Titus Schleyer; Bernd Schneidinger; Wolfgang Petrich
Journal:  Nat Med       Date:  2019-01-07       Impact factor: 53.440

5.  Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).

Authors:  William H Herman; Wen Ye; Simon J Griffin; Rebecca K Simmons; Melanie J Davies; Kamlesh Khunti; Guy E H M Rutten; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen; Morton B Brown; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2015-05-18       Impact factor: 19.112

Review 6.  Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications.

Authors:  Gursimer Jeet; J S Thakur; Shankar Prinja; Meenu Singh
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

Review 7.  Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings?

Authors:  Brian Wahl; Aline Cossy-Gantner; Stefan Germann; Nina R Schwalbe
Journal:  BMJ Glob Health       Date:  2018-08-29

8.  Challenges in diabetes management with particular reference to India.

Authors:  Kavita Venkataraman; A T Kannan; Viswanathan Mohan
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07

9.  Screening for diabetes and prediabetes should be cost-saving in patients at high risk.

Authors:  Ranee Chatterjee; K M Venkat Narayan; Joseph Lipscomb; Sandra L Jackson; Qi Long; Ming Zhu; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

Review 10.  Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension.

Authors:  Raghupathy Anchala; Nanda K Kannuri; Hira Pant; Hassan Khan; Oscar H Franco; Emanuele Di Angelantonio; Dorairaj Prabhakaran
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844

View more
  4 in total

1.  Usefulness of Machine Learning for Identification of Referable Diabetic Retinopathy in a Large-Scale Population-Based Study.

Authors:  Cheng Yang; Qingyang Liu; Haike Guo; Min Zhang; Lixin Zhang; Guanrong Zhang; Jin Zeng; Zhongning Huang; Qianli Meng; Ying Cui
Journal:  Front Med (Lausanne)       Date:  2021-12-09

Review 2.  Machine learning and deep learning predictive models for type 2 diabetes: a systematic review.

Authors:  Luis Fregoso-Aparicio; Julieta Noguez; Luis Montesinos; José A García-García
Journal:  Diabetol Metab Syndr       Date:  2021-12-20       Impact factor: 3.320

Review 3.  Machine learning for diabetes clinical decision support: a review.

Authors:  Ashwini Tuppad; Shantala Devi Patil
Journal:  Adv Comput Intell       Date:  2022-04-13

4.  Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries.

Authors:  Sheikh Mohammed Shariful Islam; Ashis Talukder; Md Abdul Awal; Md Muhammad Umer Siddiqui; Md Martuza Ahamad; Benojir Ahammed; Lal B Rawal; Roohallah Alizadehsani; Jemal Abawajy; Liliana Laranjo; Clara K Chow; Ralph Maddison
Journal:  Front Cardiovasc Med       Date:  2022-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.